General Atlantic related stories
All articles and analysis
Five ESG issues to watchFrom a heightened focus on human rights considerations to responsible AI integration, the ESG sphere is witnessing dynamic transformations.
Burgeoning strategies, alternative capital sources and new tech are shifting the PE landscapeAt the NEXUS 2024 event, private markets leaders discussed how private equity is evolving. Key topics included adapting to macroeconomic pressures, finding new capital sources and exploring AI's impact.
Future 40 Leaders - 2024: DealmakersFrom sports investments to secondaries transactions, meet the dealmakers making a name for themselves in the industry.
Side Letter: PE's strategic savioursStrategic buyers were a comparative bright spot for exits last year, thanks (in part, at least) to their deep pockets. Plus: alternatives managers are bracing themselves for a rise in regulatory fines. Here's today's brief, for our valued subscribers only.
Side Letter: Trust issuesWhat antitrust measures could mean for the private equity industry. Plus: the secondaries market may see yet another offering for the private wealth channel; and why the private markets could have a significant role to play in Malaysia. Here's today's brief, for our valued subscribers only.
PEI Awards 2023: Americas winnersBlackstone picks up the award for large-cap firm of the year after reaching $1trn in AUM.
What's behind the increase in appetite for GP stakes funds?PEI recently caught up with Joseph Lombardo, head of private equity general partner advisory at Houlihan Lokey, to discuss why LPs appear to be warming to the fund of firms strategy.
Side Letter: Top fundraising tips revealedHot tips from IR professionals on how to keep LPs engaged. Plus: PE investment in Asia healthcare is down and another firm lowers its fundraising target. Here's today's brief, for our valued subscribers only.
Side Letter: CDPQ's partial PE sale; CalPERS' mixed bag; APAC's deal insurance driveIn a cash-strapped market, Canada's CDPQ is attempting partial sales of its PE portfolio to generate liquidity. Plus: CalPERS posted a return last year despite losses in PE and real estate; and why APAC buyers are pushing for insurance coverage. Here's today's brief, for our valued subscribers only.
Private equity locks in on life sciencesAs the sector sustains market interest through wider volatility, GPs are sharpening their investment theses and building deeper sector and operational expertise to remain competitive.